Innovative AI Advances Risk Profiling for HER2+ Breast Cancer Patients Novellia's Project EVOLVE integrates AI data analysis to enhance the management of ILD in HER2-positive breast cancer care, improving patient outcomes.

Innovative AI Advances Risk Profiling for HER2+ Breast Cancer Patients #USA #San_Antonio #Project_EVOLVE #HER2+_Breast_Cancer #Novellia